Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, glycyrrhizin zinc granule...
WIT DYNE released its performance for the first three quarters, with a net profit attributable to the parent company of 408 million yuan, a year-on-year increase of 11.67%
WIT DYNE: The net profit for the third quarter was 70.5981 million yuan, a year-on-year increase of 110.42%
WIT DYNE: A cash dividend of 5 yuan for every 10 shares
WIT DYNE released its performance for the first half of the year, with a net profit attributable to the parent company of 337 million yuan, an increase of 1.69%
WIT DYNE subsidiary signs general distribution contract for melatonin granules (Manlejing)
WIT DYNE: Shareholder Guo Weisong increased his stake in the company to 3.7%